| CAS ID: | 128794-94-5 |
| Molecular Formula: | C23H31NO7 |
| Molecular Weight: | 433.5 g/mol |
| Monoisotopic Mass: | 433.2101 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RS-61443 | MYFENAX | MYCOPHENOLATE MOFETIL | CELLCEPT | RS-61443-190 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | ARZIP |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 25366137 | Target ID | |
| Uniprot ID | Name | ||
| Model | rat | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00908830 | Disease | Cystic fibrosis |
| Phase | Status | Completed | |
| First Received | May 27, 2009 | Last Verified | August 6, 2018 |
| Sponsor | University of Michigan | ||
Trial Record 2
| ClinicalTrial ID | NCT02096107 | Disease | Renal fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | March 26, 2014 | Last Verified | August 8, 2018 |
| Sponsor | Medical University of South Carolina | ||
Trial Record 3
| ClinicalTrial ID | NCT01707849 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | October 16, 2012 | Last Verified | February 7, 2018 |
| Sponsor | Hospital Vall d'Hebron | ||
Trial Record 4
| ClinicalTrial ID | NCT02370693 | Disease | Systemic sclerosis |
| Phase | Phase 2 | Status | Recruiting |
| First Received | February 25, 2015 | Last Verified | March 13, 2019 |
| Sponsor | Northwestern University | ||
Trial Record 5
| ClinicalTrial ID | NCT00538265 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | October 2, 2007 | Last Verified | February 3, 2011 |
| Sponsor | University Hospital, Toulouse | ||
Trial Record 6
| ClinicalTrial ID | NCT01860183 | Disease | Renal fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | May 22, 2013 | Last Verified | January 30, 2014 |
| Sponsor | Clinical Hospital Merkur | ||
Trial Record 7
| ClinicalTrial ID | NCT00975663 | Disease | Cystic fibrosis |
| Phase | Phase 4 | Status | Terminated |
| First Received | September 11, 2009 | Last Verified | April 26, 2011 |
| Sponsor | University Hospital, Limoges | ||
Trial Record 8
| ClinicalTrial ID | NCT00817687 | Disease | Renal fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | January 6, 2009 | Last Verified | July 9, 2012 |
| Sponsor | Hoffmann-La Roche | ||
Trial Record 9
| ClinicalTrial ID | NCT02990286 | Disease | Pulmonary fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | December 13, 2016 | Last Verified | May 8, 2017 |
| Sponsor | University Hospital, Tours | ||
| PubChem: | 5281078 |
| ChEMBL: | CHEMBL1456 |